RxDoctor Payments Data

Robert Moore, MD

Family Medicine · Jackson, MSNPI 1841281276

Payments from drug & device makers

$2,363in general payments, 2019–2025

Across 136 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Pfizer$205
  • Novo Nordisk$148
  • Lilly USA, LLC$121
  • Indivior Inc.$98
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$44
  • plus $133 from 7 others

What the payments were for

  • Food & beverage$2,363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,363 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$76,385
Medicare patients
170
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide128$136,293
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl341$52,874
MounjaroTirzepatide32$39,884
TrulicityDulaglutide15$28,845
JanuviaSitagliptin Phosphate30$23,133
LinzessLinaclotide24$19,352
FarxigaDapagliflozin Propanediol14$16,668
VraylarCariprazine Hcl11$15,480
Tresiba Flextouch U-200Insulin Degludec15$15,045
EliquisApixaban12$12,034
ZubsolvBuprenorphine Hcl/Naloxone Hcl14$8,063
SuboxoneBuprenorphine Hcl/Naloxone Hcl18$7,304
MitigareColchicine12$4,861
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$3,279
Albuterol Sulfate HfaAlbuterol Sulfate104$3,075

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog Mix 70-30$148$138,737140 claims
Lilly USA, LLCMounjaro, Trulicity$121$68,72947 claims
AbbVieLinzess, Vraylar$15$34,83235 claims
PfizerEliquis$205$12,03412 claims
Orexo US, Inc.Zubsolv$26$8,06314 claims
Indivior Inc.Suboxone$98$7,30418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →